PKU HealthCare (SZ:000788) Xin Lang Cai Jing·2025-10-30 01:33Core Viewpoint - The chairman and president of Beijing University Pharmaceutical (北大医药) has been detained for criminal investigation, but the company's control and operations remain stable [1][2]. Group 1: Company Leadership and Control - Xu Xiren, the chairman and president, has been detained and is currently unable to perform his duties [1]. - The company has appointed Chen Yuezhong as acting chairman and Yu Mengchuan as acting president during Xu's absence [1]. - Xu Xiren became the actual controller of the company after acquiring a 22.22% stake through a transaction valued at approximately 8.7 billion yuan, while his actual expenditure was only 33 million yuan [1]. Group 2: Company Background and Changes - Beijing University Pharmaceutical was established in 1965 and listed on the Shenzhen Stock Exchange in 1997 [2]. - The company is undergoing a "de-BNU" process, indicating a shift away from its historical ties with Peking University, with plans for name changes to reflect this transition [2]. Group 3: Financial Performance - In the first half of the year, the company reported revenue of 957 million yuan, a decrease of 5.04% year-on-year, while net profit attributable to shareholders was 100 million yuan, an increase of 15.51% [3]. - The increase in net profit is attributed to changes in the revenue structure of key products and improved profitability through cost reduction and efficiency enhancement [3]. Group 4: Market Performance - As of October 29, the company's stock price decreased by 0.16%, closing at 6.17 yuan per share, with a market capitalization of 3.677 billion yuan [4].